Clinical Study on the Healing of Distal Radius Fractures With Conservative Treatment Assisted by Fu's Subcutaneous Needling

Launched by GUANGZHOU UNIVERSITY OF CHINESE MEDICINE · Jun 27, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help heal broken wrists, specifically fractures of the distal radius (the part of your wrist near the thumb). Researchers want to see if adding a treatment called Fu’s subcutaneous needling (FSN)—a type of gentle needling under the skin—along with regular rehabilitation exercises can help bones heal faster and improve wrist function better than rehabilitation exercises alone.

Adults between 18 and 85 years old who have recently had a wrist fracture caused by an injury and treated without surgery may be eligible to join. Participants will receive either the real FSN treatment or a “sham” (fake) version, along with standard wrist exercises, over about eight weeks. They will have regular check-ups to look at X-rays, assess pain, swelling, wrist movement, and how well they can use their wrist in daily activities. The goal is to find out if FSN can safely speed up healing and improve recovery. If you or a family member have a recent wrist fracture and want to learn more about this study, this trial might be an option to consider.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Participants meeting the diagnostic criteria for distal radius fractures as outlined in both the Evidence-Based Guidelines for Diagnosis and Treatment of Adult Distal Radius Fractures (2024) (10) and the clinical practice guidelines (CPG) jointly issued by the American Academy of Orthopaedic Surgeons (AAOS) and the American Society for Surgery of the Hand (ASSH) (11), while also satisfying the following conditions, will be eligible for enrollment:
• • 1. Within 1 week post closed reduction and small splint immobilization treatment.
• • 2. Aged between 18 and 85 years (inclusive).
• • 3. Fracture caused by trauma.
• • 4. Acute fracture (≤2 weeks) or first-time fracture.
• • 5. No prior history of receiving Fu's subcutaneous needling therapy.
• • 6. Signed informed consent form obtained.
• Exclusion Criteria:
• • 1. Pathological, open, or nonacute fractures (\>2 weeks since injury).
• • 2. Patients with thrombocytopenia, bleeding tendency, or coagulation disorders (INR \>1.5 or platelet count \<50×10⁹/L).
• • 3. Cognitive impairment or psychiatric disorders affecting treatment compliance and follow-up.
• • 4. Local skin lesions, pregnancy, or lactation.
• • 5. History of syncope during Fu's subcutaneous needling therapy or intolerance to the procedure.
• • 6. Participation in other interventional clinical trials within the past 3 months.